Cortical effects of quetiapine in first-episode schizophrenia: A preliminary functional magnetic resonance imaging study

H M Jones, M J Brammer, M O'Toole, T Taylor, R I Ohlsen, R G Brown, R Purvis, S Williams, L S Pilowsky

Research output: Contribution to journalArticlepeer-review

47 Citations (Scopus)

Abstract

Background: Quetiapine improves both psychotic symptoms and cognitive function in schizophrenia. The neural basis of these actions is poorly understood. Methods: Three subject groups underwent a single functional magnetic resonance imaging (fMRI) session: drug-naive (n = 7) and quetiapine-treated samples of patients with schizophrenia (n = 8)and a healthy control group (n = 8). The fMRI session included an overt verbal fluency task and a passive auditory stimulation task. Results: In the verbal fluency task, There was significantly increased activation in the left inferior frontal cortex in the quetiapine-treated patient, and the healthy control sample compared with the drug-naive sample. During auditory stimulation, the healthy control group and stably treated group produced significantly greater activation in the superior temporal gyrus than the drug-naive sample. Conclusions: Quetiapine treatment is associated with altered blood oxygen level-dependent responses in both the prefrontal and temporal cortex that cannot be accounted,for by improved task performance subsequent to drug treatment.
Original languageEnglish
Pages (from-to)938 - 942
Number of pages5
JournalBiological psychiatry
Volume56
Issue number12
DOIs
Publication statusPublished - 15 Dec 2004

Fingerprint

Dive into the research topics of 'Cortical effects of quetiapine in first-episode schizophrenia: A preliminary functional magnetic resonance imaging study'. Together they form a unique fingerprint.

Cite this